Skip to main content

Table 2 Statistical analysis of five galectins expression versus clinicopathological data

From: Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications

Clinical data

p value

 

LGALS1

LGALS3

LGALS4

LGALS8

LGALS9

Age

0.587

0.439

0.890

0.360

0.412

parity

0.332

0.005

0.005

0.519

0.469

menarche

0.747

0.543

0.074

0.625

0.367

BMI

0.299

0.325

0.363

0.146

0.161

Menopause

0.948

0.281

1

0.662

0.261

Medical comorbidities

0.005

0.206

0.008

0.015

0.071

Surgical comorbidities

0.332

0.005

0.005

0.519

0.469

ca125

0.126

0.39

0.115

0.425

0.490

CEA

0.846

0.438

0.484

0.677

0.623

AFP

0.377

0.591

0.374

0.394

0.378

ca19.9

0.757

0.431

0.039

0.481

0.672

Organ metastasis

0.414

0.818

0.206

0.591

0.396

lymph node metastasis

0.228

0.044

0.088

0.178

0.013

FIGO STAGING

0.002

0.575

0.426

0.156

0.002

Cytology

0.060

0.777

0.416

0.922

0.912

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us